跳至主要内容
临床试验/EUCTR2005-005809-38-GB
EUCTR2005-005809-38-GB进行中(未招募)1 期

Does prophylactic N acetylcysteine reduce the incidence of contrast nephropathy in patients undergoing peripheral angiography - NAC as a Nehroprotective agent in Peripheral Angiography

Research & Development Department, Addenbrookes Hospital0 个研究点目标入组 40 人开始时间: 2006年1月10日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Any patient undergoing peripheral angiography in the Cambridge Vascular Unit, Addenbrooke’s Hospital, Cambridge who consents to participation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Any patient undergoing peripheral angiography in Cambridge Vascular Unit,
  • Any patient that does not consent to participation in the study.
  • Any patient under the age of 18 years
  • Any patient with established renal failure on renal replacement therapy (dialysis).

研究者

发起方
Research & Development Department, Addenbrookes Hospital

相似试验